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Abstract   
 
Objectives  
To describe changes in prevalence of hypertension, diabetes, HIV and tuberculosis, and prevalence of co-
morbidity, and to investigate associations between each condition, and combinations of conditions, with self-
reported general health and hospital admission.   
 
Methods  
This study utilised data from a longitudinal population-based HIV and health surveillance cohort, conducted by 




Prevalence of hypertension, HIV and diabetes increased from 2009-2015, and prevalence of tuberculosis 
decreased. Among 47,334 participants, 81% were female, hypertension and diabetes were the commonest 
conditions over age 50 years, whereas HIV was most common under 50 years. Comorbidity of communicable 
and non-communicable conditions was commonest in 40-60 year olds. The adjusted odd ratios (OR) for better 
self-reported general health with multimorbidity were 0.53 (95% CI 0.51-0.56), 0.29 (95% CI 0.27-0.29), 0.25 
(95% CI 0.21-0.37) and 0.21 (95% CI 0.12-0.37) for one, two three and four conditions, respectively, compared 
to no conditions. Tuberculosis was most strongly and inversely associated with better general health (OR 0.34 
(0.31-0.37) and most strongly associated with hospital admission (OR 3.26 (2.32-2.99)).  
 
Conclusion  
The high prevalence of communicable and non-communicable conditions in this rural South African population 
is giving rise to a burden of multimorbidity, as increased access to antiretroviral treatment has reduced 
mortality in people with HIV. Health care systems must adapt by working towards integrated primary care for 
HIV/AIDS and non-communicable diseases. 
 





The burden of non-communicable diseases (NCDs), including hypertension and type 2 diabetes mellitus is 
increasing alongside established HIV and tuberculosis epidemics among people in sub-Saharan Africa [1-4]. 
This is fuelled by increasing urbanisation, changing diet, sedentary lifestyles [5] and, amongst people with HIV, 
possibly by metabolic side effects of life-long antiretroviral treatment [6]. The World Health Organisation has 
predicted a 17% increase in global NCD deaths from 2013 to 2020, with low and middle-income countries 
(LMICs) currently already bearing 86% of the burden of these premature deaths [7]. Prevalence of diabetes in 
Southern Africa is estimated at 14% amongst older African adults, and the prevalence of hypertension at over 
50% of older adults [8]. Community-based epidemiological studies on the prevalence of comorbidities amongst 
the HIV population in South Africa, Uganda and Tanzania show considerable comorbidity of hypertension in 
people with HIV, with prevalences of up to 23% [9-14]. 
 
Health services are poorly equipped to deal with this newly emerging burden of disease. A national survey of 
primary care attenders in South Africa found that hypertension was the most common reason for attendance 
to primary care clinics, and that NCDs accounted for 14% of all visits [15]. This number is thought to be an 
underestimation [16]. A recent study across six sites in sub-Saharan Africa found that despite South Africa 
having the highest blood pressure, 60% of men and 46% of women with hypertension in South Africa were 
unaware of it [17]. Despite evidence of the increasing prevalence of multimorbidity in sub-Saharan Africa, 
evidence of its impact of multimorbidity on quality of life and hospitalisation is scarce [2]. Secondary analyses 
from the WHO-SAGE 2007-2010, however, found that healthcare utilisation within the last year increased from 
26% for those without any NCDs to 81% for those with multimorbidity, and this was highest in South Africa 
compared to other LMICs [18]. Another study in South Africa found significant multimorbidity and unmet 
treatment needs among patients with NCDs [14]. 
 
Most evidence of multimorbidity comes from high income countries and little is known about multimorbidity 
in LMICs, particularly in rural sub-Saharan Africa [19, 20]. More data is needed to further elucidate the 
prevalence and patterns of multimorbidity in this region, as well as its effects on general health and on 
healthcare utilisation. Defining this burden of NCDs among people living with HIV will allow a better 
understanding of multimorbidity, informing future primary healthcare service planning to better manage these 
co-existing conditions. A 2018 Academy of Medical Sciences report on global multimorbidity research 
concluded that future research on changing trends and patterns of multimorbidity, and its effects on burden of 
disease and health care, were priorities [2], which we address in this study.   
 
The Africa Health Research Institute (ARHI), is a demographic surveillance area in a rural socioeconomically 
deprived area of KwaZulu-Natal, South Africa, with high HIV prevalence. It follows a cohort of about 85,000 
adults with annual community-based surveys including questionnaires and HIV testing and has until 2018 
focused on HIV and tuberculosis research [21]. Surveys include questions on recent diagnosis and treatment 
for hypertension, diabetes and tuberculosis. In 2010 the survey also measured blood pressure and found that 
26% of participants had hypertension [21]. In the present study we utilised data from population-based 
surveys of the demographic surveillance area conducted by ARHI from 2009-2015. We investigated a) changes 
in the prevalence of hypertension (HPT), diabetes (DM), HIV and tuberculosis, b) prevalence of comorbidities, 
and c) associations between each condition, and combination of conditions, with self-reported general health 





Study Design and Population  
This was a cohort study using data from a longitudinal population-based HIV and health surveillance study, 
conducted by the Africa Health Research Institute (AHRI previously known as the Africa Centre for Health and 
Population Studies), based in the Umkhanyakude district of rural KwaZulu-Natal, South Africa [21]. The study 
population included approximately 85,000 people who were members for around 11,000 households. To be 
eligible, individuals must be a member of a household within the surveillance area, but not necessarily a 
permanent resident within it. For this analysis, the study population included all eligible adults aged ≥15 years, 
who were surveyed annually between 2004 and 2015 and who had been tested for HIV. Non-participation was 
due to absence or declined consent.   
 
Data Collection 
Participants were surveyed at their homes, including interviewer-administered questionnaires and HIV tests. 
The study aimed to gather data from each eligible individual repeatedly every year, but most individuals did 
not participate every year because they were absent from their homes at the time of a survey or declined to 
participate.  After providing written informed consent, participants were asked to give finger prick blood 
samples which were used to prepare dried blood spots (DBS) for HIV testing. HIV status was determined by 
antibody testing in the AHRI virology laboratory with a broad-based HIV-1/HIV-2 enzyme-linked 
immunosorbent assay (ELISA) (Vironostika® HIV-1 Microelisa System (Biomérieux, Durham, NC, USA) followed 
by a confirmatory ELISA (Wellcozyme HIV 1 + 2 GACELISA; Murex Diagnostics Benelux B.V., Breukelen, The 
Netherlands) [21]. 
 
Self-reported measurements of the diagnosis or current ongoing treatment of hypertension, diabetes mellitus 
and tuberculosis within the last 12 months were obtained by interviewer-administered questionnaires. 
Participants were assumed to have HIV if they had ever testing positive in previous surveys, and to have 
hypertension or diabetes if they reported to have a diagnosis or treatment for the respective condition 
currently, during the previous 12 months or in a previous survey. Tuberculosis was only coded as present if 
reportedly diagnosed or treated during the previous 12 months.  Self-reported hospital admission occurring 
within the last 12 months was also recorded, both as any admission and as number of admissions.  
 
General health status was measured as a single ordered categorical variable by asking one item of the General 
Health Questionnaire 12, “Describe your general health at present” [22]. Possible responses were excellent, 
very good, good, fair and poor, with the first three categories were combined into one. 
 
Statistical Analysis  
For each annual survey, estimations of the prevalence of each condition, and combinations of conditions were 
calculated. To investigate associations between these conditions and general health and hospital admission, 
we used Cuzick’s non-parametric test for trend and chi square test, respectively. We constructed random 
effects ordinal logistic regression, logistic regression and Poisson regression models with general health, at 
least one hospital admission and number of hospital admissions as outcomes, respectively, with HIV, 
hypertension, diabetes, tuberculosis, age, age2, and year as time-varying covariates, with sex as a time-
invariant covariate, and with individual as a random effect. We constructed an alternative random effects 
ordinal logistic regression model with general health as outcome and number of conditions as a covariate 
instead of HIV, hypertension, diabetes, tuberculosis as separate covariates. We also constructed equivalent 
general estimating equation logistic and Poisson models, with robust adjustment and exchangeable 
correlation, so as to estimate population average effects [23]. To investigate factors independently associated 
with missing HIV, hypertension, diabetes, tuberculosis, general health and hospital admission data in any year, 
we constructed random effects logistic regression models,  with missingness of each of these variables as 
binary outcomes, and with all other outcomes and covariates used in the previous models as covariates.  
Analyses were done using Stata version 15.0, except for the general estimating equation ordinal logistic model 
which was done in R []24] A p-value of 0.05 or less was considered statistically significant. Venn diagrams 
showing prevalence of comorbidities, with each area approximately proportional to prevalence, were 
constructed using EulerApe 3.0. 
 
Ethics Approval  
Ethical approval for the demographic surveillance study and analyses of these data was granted by the 
Biomedical Research Ethics Committee of the University of KwaZulu-Natal, South Africa.  Participants provided 




47,334 people were included in the present study, of whom between 14,478 and 17,890 participated each 
year, and 44,396 participated at least twice. The median age was 32 (interquartile range 20-52) years and 53% 
were female.   The prevalence of hypertension, diabetes and HIV increased over the years from 2009-2015, 
with the HIV having the highest followed by hypertension, diabetes and tuberculosis, respectively, and with 
hypertension prevalence approaching that of HIV by 2014. The prevalence of tuberculosis decreased after 
2010 (Figure 1). The proportion of participants with two or more conditions increased from 8.4% in 2009 to 
13.2% in 2015.  
 
Of the four conditions, HIV had the highest prevalence under 40 years of age, and at ages under 50, HIV was 
the most common condition in females (Figure 2). Hypertension was the most prevalent condition above 40 
years of age in females and above 50 years in males. Hypertension and diabetes were substantially more 
common in females than in males, whereas tuberculosis was more common in males.  
 
Participants with each condition were significantly less likely to report better general health and more likely to 
report hospital admission during the past 12 months (Table 1).  In ordinal logistic regression analyses, 
tuberculosis was most strongly and inversely associated with better general health, followed by hypertension, 
diabetes and HIV respectively (Table 2). In an alternative analysis with number of conditions as covariate, the 
adjusted odds ratio for better self-reported general health of participants were 0.53 (95% CI 0.51-0.56), 0.29 
(95% CI 0.27-0.29), 0.25 (95% CI 0.21-0.37) and 0.21 (95% CI 0.12-0.37) for one disease, two diseases, three 
diseases and four diseases respectively, compared to having none of these conditions.  In logistic regression 
analyses tuberculosis was most strongly associated with hospital admission, closely followed by diabetes 
(Table 2). HIV and hypertension were much less strongly, and similarly, associated with hospital admission. Of 
5061 occasions when participants reported hospital admission during the last year, 597 (11.8%) reported more 
than one admission. Associations between covariates and numbers of hospital admissions in the past year 
were similar to associations with at least one admission (Table 2). General estimating equation models 
produced similar results to random effects models, except that with hospital admission and number of 
hospital admissions as outcomes, odds ratios and incidence rate ratio models for HIV, hypertension, diabetes 
and tuberculosis were slightly smaller with general estimating equation models (Table 2).  
 
Data on HIV, hypertension, diabetes, tuberculosis, general health and hospital admission were missing for 
30%, 14%, 10%, 21%, 20% and 20% of interviews, respectively. Data on HIV were more likely to be missing in 
males and in participants who reported better general health, and were less likely to be missing if they 
reported hospital admission, hypertension or tuberculosis, and in later survey years (Table 3). Data on 
tuberculosis were more likely to be missing in participants with HIV or diabetes or who were male, and in later 
years. In equivalent models, not tabulated, only later survey years were independently associated with missing 
hypertension data (adjusted odds ratio 1.22 (95% confidence interval 1.14-1.13) per year); only tuberculosis 
and later years were independently associated with missing diabetes data (adjusted odds ratios 3.74 (2.44-
5.76) and 1.11 (1.04-1.19) respectively. Data on general health were more likely to be missing in participants 
with hypertension and in later survey years (Table 3). No variable independently predicted missing hospital 
admission data.  
 
Comorbidity was most common amongst those with diabetes, 85.4% of whom also had hypertension, and 
12.2% also had hypertension and HIV (Figure 3).  Comorbidity was also common in those with tuberculosis, of 
whom 74.4% also had HIV and 10.3% had HIV and hypertension. 12.1% of those with HIV also had 
hypertension. Of those aged over 40 years, 66% had at least one condition and 18.4% had at least two, with 
11.5% having both diabetes and hypertension.  
 
Discussion  
This study described the high burden of NCD and communicable disease comorbidity in this rural South African 
population, with NCD prevalence comparable to that of data from other South African studies [5, 9, 10]. 
 
In this study population, with median age 32 years, HIV had the highest prevalence of the four conditions, with 
31.7% being HIV+ in 2015, compared to the national prevalence of HIV in South Africa of 12.5% in the same 
year [25]. This is very closely followed by hypertension with 27% of participants being affected. This is 
congruent with emerging studies based on primary care clinic attendants which show that hypertension is the 
commonest presenting condition across South Africa [5, 15]. Hypertension and HIV comorbidity in this sample 
was relatively common, with 15.2% of those with hypertension also being HIV+. More people are living longer 
with HIV, with AIDS-related deaths declining consistently since 2007 because of antiretroviral treatment 
according to national data [26], and people are hence more likely to develop other chronic conditions. Recent 
studies show a high prevalence of dysglycaemia, dyslipidaemia and increased visceral adiposity in HIV-infected 
patients on ART, thereby predisposing to hypertension and diabetes [26, 27]. While efforts to maintain 
progress with ART must continue, our findings point to a need to expand our focus to enable effective 
management of communicable disease and NCD comorbidity particularly among lower socioeconomic groups 
[6, 10].  
 
Comorbidity was strongly associated with age. Overlap between communicable disease and NCDs is seen 
especially in the over 40 years age group, where chronic NCD increases alongside HIV. The prevalence of 
chronic NCD in this age group is notable, with hypertension and diabetes being the most common comorbidity 
overall, with 70.5% of those with diabetes having hypertension, and with both chronic conditions 
independently increasing with age. A national study based on over 50-year olds estimated hypertension 
prevalence to be at 77.3% [28]. A similar study of primary care clinic patients in a peri-urban area of South 
Africa, found that the most common comorbidity was hypertension and diabetes which increased with 
increasing age [5]. The presence of these comorbidities as the population ages is likely to complicate 
management, particularly as more people with HIV survive longer on ART. However, despite this trend, little 
attention has been paid to HIV and NCDs in the older population [29]. 
 
The national South African General Household Survey in 2010 demonstrated that the prevalence of 
hypertension in women was about twice the prevalence in men, with the gap narrowing for older adults [30]. 
These results are congruent with our findings. Sociocultural factors may contribute, for example it has been 
argued that black African women perceive being overweight, a risk factor for hypertension and diabetes, as 
desirable because it signifies affluence, beauty and being HIV negative [9, 31]. Although being underweight is 
stigmatised, however, because of its and its association with HIV/AIDS and tuberculosis, a recent study found 
no association between underweight status and HIV status [31]. Another study pointed to the high levels of 
tobacco smoking particularly amongst women as a risk factor for hypertension [32].   
 
All four conditions were strongly and independently associated with worse self-reported general health and 
with hospital admission. The random effects models (estimating subject specific effects)  and the generalised 
estimating equation models (estimating population average effects) produced similar results. The random 
effects models are arguably preferable in this study, because they are more appropriate for estimating effects 
of time-varying covariates like comorbidities, and they do not assume that the missingness of data is 
independent of other variables in the analysis [23].  
 
Tuberculosis was most strongly associated with both outcomes. However, diabetes was almost as strongly 
associated with hospital admission as tuberculosis was, highlighting the growing burden of illness that diabetes 
will cause as it becomes more common. A study from Ghana, also a middle-income country, showed increased 
diabetes admission rates across the last three decades, attributing to complications such as diabetic 
ketoacidosis, symptomatic hypoglycaemia and end-organ complications [33]. The severity of diagnosed 
diabetes could explain the strong association between diabetes and hospitalisation. Statistics South Africa 
reported that in 2016 diabetes was South Africa’s second most common cause of death, second only to 
tuberculosis, and was the most common cause of death in women (7.2%) and the second common cause of 
death in men (5.5%) [34]. This highlights the importance of improving diabetes prevention and treatment in 
LMICs, where an estimated 77% of people with diabetes worldwide live [35]. It is surprising that HIV was not 
more strongly associated with worse general health and hospitalisation than hypertension was, considering 
that hypertension is usually asymptomatic. This finding suggests that most people with HIV were at early 
stages of infection or were well controlled on antiretroviral treatment.  
 
Our findings suggest that the impact of multimorbidity on self-reported poor general health outcomes is 
multiplicative the more conditions suffered. This is consistent with data taken from six LMICs showing a 
statistically significant negative effect on four quality of life outcomes, and that each outcome showed poorer 
results the greater the number of chronic conditions suffered [19]. These results contribute to evidence on the 
nature of disease interactions in multimorbidity.  
 
A strength of the study is that we include a large community-based sample of 47,334 participants which 
increases the generalisability of the findings. The demographic information system collects information on 
resident and non-resident members of households, making a distinction between membership and residency. 
Obtaining information on non-resident members is crucial, as understanding patterns of HIV transmission 
within rural areas requires knowledge about patterns of circulation and about sexual contacts between 
residents and non-resident partners. This longitudinal study contributes to current evidence gaps, allowing a 
better understanding of the changing prevalence of multimorbidity over time [2]. 
 
A limitation of the study was the use of self-reported diagnoses and treatment of hypertension, diabetes and 
tuberculosis, as well as self-reported measurements of general health and hospital admission, which would 
less accurate than objective assessment. Furthermore, the consent rates for HIV testing was low, decreasing 
from 60% in 2003-2004, to 40% in 2005-2006, and almost half did not answer questions about general health 
and hospital admissions leading to possible selection bias [21]. Non-participation could be explained by 
migration of healthier individuals in and out of the surveillance area, which could also cause selection bias. The 
General Health Questionnaire (GHQ-12) was used, which widely validated in general and clinical populations 
and found to be reliable [36]. However, for this study the responses ‘good’, ‘very good’ and ‘excellent’ were 
combined, because they could not be clearly distinguished when translated in to Zulu, thereby reducing the 
instrument’s discriminating value. AHRI is currently carrying out community-based tuberculosis, blood 
pressure and diabetes testing as well as HIV testing in this study population, which will provide more accurate 
estimates of the prevalence of comorbidity and will allow prospective assessment of the effects of each 
condition on health outcomes and health care use. Data on HIV were most likely to be missing, because they 
required additional consent and testing, even though results of previous positive tests had been carried 
forward to subsequent years. HIV data were less likely to be missing in participants with indicators of worse 
health and with comorbidities (Table 3), suggesting that their health concerns increased their willingness to be 
tested. Males were less likely to have been tested for HIV -  in keeping with less uptake of HIV testing by men 
in South Africa nationally - and to have missing tuberculosis data.  Missing comorbidity or health outcome data 
were more likely in later years, but otherwise were not consistently predicted by other covariates or 
outcomes.  
 
Chronic disease is often underdiagnosed, leading to underestimation of the true prevalence of NCDs in the 
population. There needs to be a greater priority for chronic disease management, particularly in the context of 
a rapidly growing burden of communicable and NCD comorbidity. Evidence from the Cape Peninsula, South 
Africa, found that care for hypertensive and diabetic patients in community health centres was suboptimal, 
with uncontrolled hypertension in 50% of patients, high prevalence of unrecorded diabetic complications and 
suboptimal glycaemic control [37]. Issues of access and quality must be taken into consideration, along with 
culturally-appropriate approaches to behaviour change and chronic disease management. 
 
In line with the WHO Innovative Care for Chronic Conditions report [38], we argue that health care systems 
must adapt to this rising burden by working towards an integrated model of care for HIV/AIDs and NCDs in the 
region. The acute care paradigm no longer meets the needs of many patients. Engagement with local 
communities and healthcare teams must be strengthened to ensure patients are informed, well-educated and 
empowered to take control of their own health [39].  
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Figure 1: Prevalence (%) of HIV, hypertension, diabetes mellitus and tuberculosis (TB) annually 
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Figure 2: Prevalence (%) of HIV, hypertension (HTN), diabetes mellitus (DM) and tuberculosis 
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Table 1: Association between disease and general health score and hospitalisation within the last year in 2015  
Associations between each condition and general health tested with Cuzick’s non-parametric test for trend. Associations between each condition and hospital admission tested 
with chi squared rest. P<0.001 for all tests. 
 
HIV + HIV - Hypertension + Hypertension -  Diabetes + Diabetes - Tuberculosis + Tuberculosis - 
n % n % n % n % n % n % n % n % 
General 
Health 
               
Poor 
47 1.2 210 2.4 209 5.9 77 0.7 82 8.6 202 1.4 29 7.0 249 1.7 
Fair 




2,684 70.9 6,359 73.3 1,544 43.5 9,553 83.7 343 35.8 10,768 76.9 196 47.0 10,890 75.1 
TOTAL 
3,784 100.0 8,677 100.0 3,553 100.0 11,416 100.0 958 100.0 14,008 100.0 417 100.0 14,509 100.0 
Hospital 
Admission 
                
No 
3,668 96.6 8,540 98.0 3,505 97.9 11,160 97.5 925 95.9 13,732 97.7 97.7 381 14,235 97.8 
Yes 
130 3.4 175 2.0 77 2.1 281 2.5 40 4.1 324 2.3 2.3 35 327 2.2 
TOTAL 
3,798 100.0 8,715 100.0 3,582 100.0 11,441 100.0 965 100.0 14,056 100.0 100.0 416 14,562 100.0 
Table 2: Association between general health and hospitalisation, and disease and demographic characteristics: regression models 1 
 2 
* ordinal logistic regression model. ** logistic regression models. *** Poisson regression models  3 
Explanatory variables Outcome 






95% CI P value Odds ratio 95% CI P value Incidence rate 
ratio 
95% CI P value 
HIV 0.72 0.69-0.76 <0.001 1.51 1.36-1.66 <0.001 1.55 1.41-1.71 <0.001 
Hypertension  0.49 0.46-0.52 <0.001 1.45 1.28-1.65 <0.001 1.54 1.36-1.73 <0.001 
Diabetes  0.64 0.59-0.70 <0.001 2.60 2.18-3.09 <0.001 2.52 2.12-2.99 <0.001 
Tuberculosis 0.34 0.31-0.37 <0.001 3.26 2.80-3.79 <0.001 2.24 1.95-2.58 <0.001 
Male vs female 1.03 0.98-1.09 0.197 0.77 0.71-0.85 <0.001 0.80 0.73-0.89 <0.001 
Age (years) 0.91 0.91-0.92 <0.001 1.02 1.00-1.03 <0.001 1.02 1.01-1.03 0.002 
Age2 1.0004 1.0003-1.0004 <0.001 0.9997 0.9996-0.9998 <0.001 0.9997 0.9995-0.9998 <0.001 




         
HIV 0.74 0.70-0.78 <0.001 1.45 1.33-1.59 <0.001 1.56 1.39-1.75 <0.001 
Hypertension  0.51 0.51-0.48 <0.001 1.40 1.23-0.59 <0.001 1.47 1.24-1.75 <0.001 
Diabetes  0.65 0.60-0.71 <0.001 2.36 2.01-2.78 <0.001 2.36 1.91-2.92 <0.001 
Tuberculosis 0.35 0.32-0.39 <0.001 2.89 2.52-3.31 <0.001 2.43 2.10-2.81 <0.001 
Male vs female 1.04 0.99-1.10 0.112 0.80 0.72-0.88 <0.001 0.82 0.73-0.92 0.001 
Age (years) 0.91 0.91-0.92 <0.001 1.01 1.00-1.03 0.024 1.01 0.99-0.13 0.116 
Age2 1.0004 1.0003-1.0004 <0.001 0.9997 0.9995-0.9998 <0.001 0.9997 0.80-0.85 <0.001 
Year of survey 1.09 1.08-1.10 <0.001 0.83 0.81-0.85 <0.001 0.83 
0.80-0.85 <0.001 





Explanatory variables Outcomes 
 Missing HIV data Missing tuberculosis data Missing general health data 
 Odds 
ratio 
95% CI Odds 
ratio 
Odds ratio Odds ratio P value Odds ratio 95% CI P value 
General health           
 Poor (reference) 1.0   1.0      
 Fair 1.27 1.08-1.50 0.005 0.78 0.49-1.25 0.306    
 Good, very good 
or      excellent 
1.93 1.64-2.29 <0.001 0.71 0.44-1.15 0.166    
Hospital admission in 
the last year (vs none) 
0.83 0.75-0.91 <0.001 1.09 0.72-1.66 0.673 0.75 0.33-1.69 0.485 
HIV    1.35 1.09-1.67 0.005 0.91 0.65-1.26 0.551 
Hypertension  0.85 0.79-0.92 <0.001 1.22 0.94-1.59 0.141 1.61 1.11-2.31 0.011 
Diabetes  1.02 0.91-1.16 0.714 1.02 2.54-1.48 <0.001 1.11 0.69-1.77 0.669 
Tuberculosis 0.70 0.62-0.78 <0.001    0.91 0.42-1.95 0.819 
Male vs female 1.44 1.37-1.52 <0.001 1.37 1.12-1.68 0.002 1.23 0.91-1.65 0.176 
Age (years) 1.01 1.00-1.01 0.041 1.02 1.00-1.00 0.092 1.07 0.974-1.04 0.698 
Age2 0.9999 0.9998-0.9999 <0.001 0.9999 09996-1.0000 0.204 1.000 0.9997-1.0000 0.951 
Year of survey 0.86 0.86-0.87 <0.001 1.11 1.06-1.16 <0.001 1.33 1.23-1.43 <0.001 
Figure 3: Comorbidity between hypertension, diabetes, HIV and tuberculosis in 2015  9 
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 11 
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